Area of research
Microbiology · Virology
Research interest
Research interests include Reproductive tract infections research, HIV Research and Treatment, HIV/AIDS Research and Interventions, and Reproductive System and Pregnancy.
Vaginal epithelial dysfunction is mediated by the microbiome, metabolome, and mTOR signaling
Copper intrauterine device increases vaginal concentrations of inflammatory anaerobes and depletes lactobacilli compared to hormonal options in a randomized trial
Nonoptimal bacteria species induce neutrophil-driven inflammation and barrier disruption in the female genital tract
Lactic acid from vaginal microbiota enhances cervicovaginal epithelial barrier integrity by promoting tight junction protein expression
Gut microbiome signatures linked to HIV-1 reservoir size and viremia control
Changes in concentrations of cervicovaginal immune mediators across the menstrual cycle: a systematic review and meta-analysis of individual patient data
Non-<i>Lactobacillus</i>-Dominant and Polymicrobial Vaginal Microbiomes Are More Common in Younger South African Women and Predictive of Increased Risk of Human Immunodeficiency Virus Acquisition
The neovaginal microbiome of transgender women post-gender reassignment surgery
Impact of vaginal microbiome communities on HIV antiretroviral-based pre-exposure prophylaxis (PrEP) drug metabolism
Influence of dapivirine vaginal ring use on cervicovaginal immunity and functional microbiome in adolescent girls
The Evolving Facets of Bacterial Vaginosis: Implications for HIV Transmission
Increased mucosal neutrophil survival is associated with altered microbiota in HIV infection
The vaginal microbiome amplifies sex hormone‐associated cyclic changes in cervicovaginal inflammation and epithelial barrier disruption
Intestinal damage precedes mucosal immune dysfunction in SIV infection
Vaginal bacteria modify HIV tenofovir microbicide efficacy in African women
Microbiome Composition and Function Drives Wound-Healing Impairment in the Female Genital Tract
Genital injury signatures and microbiome alterations associated with depot medroxyprogesterone acetate usage and intravaginal drying practices
Microbial translocation and microbiome dysbiosis in HIV-associated immune activation
Increased levels of inflammatory cytokines in the female reproductive tract are associated with altered expression of proteases, mucosal barrier proteins, and an influx of HIV-susceptible target cells
HIV and mucosal barrier interactions: consequences for transmission and pathogenesis
Mucosal effects of tenofovir 1% gel
Molecular Signatures of Immune Activation and Epithelial Barrier Remodeling Are Enhanced during the Luteal Phase of the Menstrual Cycle: Implications for HIV Susceptibility
Author response: Mucosal effects of tenofovir 1% gel
Mucosal Integrity Factors Are Perturbed during Bacterial Vaginosis: A Proteomic Analysis
Mucosal Proteomic Profiles Associated with Female Genital Tract Inflammation
Unbiased Proteomics Analysis Demonstrates Significant Variability in Mucosal Immune Factor Expression Depending on the Site and Method of Collection